Human CCL3/MIP-1 alpha Quantikine PharmPak (50 Plates)

• Supplier: R&D Systems
• Catalog: PDMA00
• Category: ELISA Kit
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (10 µL), Serum (200 µL), EDTA Plasma (200 µL), Heparin Plasma (200 µL), Citrate Plasma (200 µL)
• Sensitivity: 10 pg/mL
• Range: 31.2 - 1,000 pg/mL (Cell Culture Supernates), 46.9 - 1,500 pg/mL (Serum, Heparin Plasma, Citrate Plasma, EDTA Plasma)
• Format: 96-well strip plate
• Description: The Quantikine Human MIP-1 alpha Immunoassay is a 3.5 or 4.5 hour solid phase ELISA designed to measure MIP-1 alpha levels in cell culture supernates, serum, and plasma
• Gene: CCL3

Product References

The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic - The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic

Ponader S, Chen SS, Buggy JJ, Balakrishnan K, Gandhi V, Wierda WG, Keating MJ, O'Brien S, Chiorazzi N, Burger JA. Blood. 2012 Feb 2;119(5):1182-9.

Alveolar fibrocyte percentage is an independent predictor of poor outcome in - Alveolar fibrocyte percentage is an independent predictor of poor outcome in

Quesnel C, Piednoir P, Gelly J, Nardelli L, Garnier M, Lecon V, Lasocki S, Bouadma L, Philip I, Elbim C, Mentre F, Soler P, Crestani B, Dehoux M. Crit Care Med. 2012 Jan;40(1):21-8.

Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to - Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to

Johnson TR, McLellan JS, Graham BS. J Virol. 2012 Feb;86(3):1339-47.

CCL3 (MIP-1alpha) plasma levels and the risk for disease progression in chronic - CCL3 (MIP-1alpha) plasma levels and the risk for disease progression in chronic

Sivina M, Hartmann E, Kipps TJ, Rassenti L, Krupnik D, Lerner S, LaPushin R, Xiao L, Huang X, Werner L, Neuberg D, Kantarjian H, O'Brien S, Wierda WG, Keating MJ, Rosenwald A, Burger JA. Blood. 2011 Feb 3;117(5):1662-9.

A phase I trial of bortezomib with temozolomide in patients with advanced - A phase I trial of bortezomib with temozolomide in patients with advanced

Su Y, Amiri KI, Horton LW, Yu Y, Ayers GD, Koehler E, Kelley MC, Puzanov I, Richmond A, Sosman JA. Clin Cancer Res. 2010 Jan 1;16(1):348-57.

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. - Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.

Mabilleau G, Sabokbar A. PLoS One. 2009;4(1):e4173.

HIV increases markers of cardiovascular risk: results from a randomized, - HIV increases markers of cardiovascular risk: results from a randomized,

Calmy A, Gayet-Ageron A, Montecucco F, Nguyen A, Mach F, Burger F, Ubolyam S, Carr A, Ruxungtham K, Hirschel B, Ananworanich J. AIDS. 2009 May 15;23(8):929-39.

Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell - Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell

Aldinucci D, Lorenzon D, Cattaruzza L, Pinto A, Gloghini A, Carbone A, Colombatti A. Int J Cancer. 2008 Feb 15;122(4):769-76.

Expression of CXC and CC type of chemokines and its receptors in tuberculous and - Expression of CXC and CC type of chemokines and its receptors in tuberculous and

Pokkali S, Das SD, R L. Cytokine. 2008 Mar;41(3):307-14.

Duffy antigen modifies the chemokine response in human endotoxemia. - Duffy antigen modifies the chemokine response in human endotoxemia.

Mayr FB, Spiel AO, Leitner JM, Firbas C, Kliegel T, Jilma-Stohlawetz P, Derendorf H, Jilma B. Crit Care Med. 2008 Jan;36(1):159-65.